- Location
- Remote (United States)
- Workplace
- Remote
- Type
- Contract
- Department
- Healthcare
- Education
- Master
- Closing date
- Today
- Source
- CareersPage
Description
Mercor is conducting a paid research study in collaboration with a leading AI research lab focused on improving healthcare. We are seeking board-certified urologists and medical oncologists in the United States who manage patients with metastatic prostate cancer to take part in a short online survey about treatment decision-making.
Responsibilities
Participants will be asked to:
Complete a structured ~30-minute online survey
Share perspectives on how you evaluate and select systemic treatments for patients with prostate cancer
Submit all responses within the given timeline
Requirements
Urologist or medical oncologist with an MD or DO
Board certified in your specialty
Hold an active, unrestricted US medical license and practice primarily in the United States
Spend at least 25% of your professional time in direct patient care
Have cared for prostate-cancer patients in the past 12 months, including at least one patient with metastatic hormone-sensitive (mHSPC) or castration-resistant (mCRPC) prostate cancer
Regularly manage metastatic prostate cancer, with primary or shared responsibility for selecting systemic treatment
Able to independently complete a ~30-minute online survey
Please note: this study is not open to anyone who has taken part in prostate-cancer market research in the past 3 months, or who (or whose immediate family) works for a pharmaceutical, diagnostics, market research, or advertising company, a wholesaler, or a specialty pharmacy.
Engagement Details
Format: Online survey
Duration: Approximately 30 minutes
Compensation: One-time payment upon successful verification of the submission
Location: Remote (United States)
Why Participate
Contribute to research shaping the next generation of healthcare AI tools
Share your real-world clinical expertise in managing advanced prostate cancer